Latest Breaking News On - Progressive fibrosis interstitial lung disease - Page 2 : comparemela.com

Inversago Pharma Inc. ("Inversago"), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, today announces the appointment of Glenn S. Vraniak to the position of Chief Financial

Inversago pharmaKostenloser wertpapierhandelGlenns vraniakGe capitalRutgers university centerCore incInversago pharma incElectronic engineering technologyManagement developmentChief financial officerEvaxion biotechExecutive viceChief executiveDiabetic nephropathyNon alcoholic steatohepatitisPrader willi syndrome